Highlight of 2023: Virtues and vices of CD4 CAR T cells

IF 3.2 4区医学 Q3 CELL BIOLOGY

Immunology & Cell Biology Pub Date : 2024-04-24 DOI:10.1111/imcb.12764

Shivali Savita Chinni, Megan F Taylor, Jessica G Borger, Kylie M Quinn

引用次数: 0

Abstract

This article for the Highlights of 2023 Series explores recent work that suggests that targeting CD4 CAR T cells may be critical for both of these challenges.

Abstract Image

查看原文本刊更多论文

2023 年的亮点：CD4 CAR T 细胞的优点和缺点。

这篇为 "2023 年亮点 "系列撰写的文章探讨了最近的研究，这些研究表明，以 CD4 CAR T 细胞为靶点可能对这两种挑战都至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Immunology & Cell Biology 医学-免疫学

CiteScore

7.50

自引率

2.50%

发文量

审稿时长

4-8 weeks

期刊介绍： The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.